(Q34187282)

English

European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies

scientific article published on 5 November 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

0 references

1 reference

based on heuristic

inferred from title

systemic lupus erythematosus

1 reference

based on heuristic

inferred from title

lupus erythematosus

1 reference

based on heuristic

inferred from title

object named as

M Aringer

3

0 references

Caroline Gordon

object named as

C Gordon

12

0 references

Yehuda Shoenfeld

17

object named as

Y Shoenfeld

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Ole Petter Rekvig

14

object named as

O P Rekvig

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Ricard Cervera i Segura

7

object named as

R Cervera

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

16

object named as

Y Sherer

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

20

object named as

A Tincani

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Munther A. Khamashta

10

object named as

M A Khamashta

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Michelle A. Petri

13

object named as

M Petri

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Stefano Bombardieri

4

object named as

S Bombardieri

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

8

object named as

A Doria

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

M Mosca

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

C Tani

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

D Boumpas

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

R Brey

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

D Jayne

9

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

A Kuhn

11

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

M Schneider

15

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

J S Smolen

18

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

R Talarico

19

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

R F van Vollenhoven

21

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

M M Ward

22

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

V P Werth

23

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

L Carmona

24

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

0 references

publication date

5 November 2009

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Annals of the Rheumatic Diseases

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

69

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1269-1274

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Disparities in lupus care and outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952401

5 July 2018

A quality indicator set for systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952401

5 July 2018

European consensus statement on the terminology used in the management of lupus glomerulonephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952401

5 July 2018

Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952401

5 July 2018

Acute viral infections in patients with systemic lupus erythematosus: description of 23 cases and review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952401

5 July 2018

EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952401

5 July 2018

Lupus erythematosus: systemic and cutaneous manifestations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952401

5 July 2018

Clinical evaluation of patients with inflammatory connective tissue diseases complicated by cytomegalovirus antigenemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952401

5 July 2018

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952401

5 July 2018

Lymphopenia at presentation is associated with increased risk of infections in patients with systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952401

5 July 2018

Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952401

5 July 2018

An international cohort study of cancer in systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952401

5 July 2018

EULAR standardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952401

5 July 2018

Specific antinuclear antibodies are associated with clinical features in systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952401

5 July 2018

Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952401

5 July 2018

Premature coronary-artery atherosclerosis in systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952401

5 July 2018

Prevention of cardiovascular disease in systemic lupus erythematosus--proposed guidelines for risk factor management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952401

5 July 2018

The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952401

5 July 2018

Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-DNA antibody tests

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952401

5 July 2018

Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952401

5 July 2018

Outcome and prognostic indicators of diffuse proliferative lupus glomerulonephritis treated with sequential oral cyclophosphamide and azathioprine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952401

5 July 2018

Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952401

5 July 2018

Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952401

5 July 2018

Outcome of renal transplantation in systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952401

5 July 2018

Cumulative rate of relapse of lupus nephritis after successful treatment with cyclophosphamide.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952401

5 July 2018

"Nephritic flares" are predictors of bad long-term renal outcome in lupus nephritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952401

5 July 2018

A controlled study of pneumococcal polysaccharide vaccine in systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952401

5 July 2018

Prevalence and risk factors of osteoporosis in female SLE patients-extended report.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952401

28 October 2018

High risk of tuberculosis in systemic lupus erythematosus?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952401

28 October 2018

Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952401

28 October 2018

Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952401

28 October 2018

Antiphospholipid antibodies predict early damage in patients with systemic lupus erythematosus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952401

28 October 2018

Increased incidence of cervical intraepithelial neoplasia in women with systemic lupus erythematosus treated with intravenous cyclophosphamide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952401

28 October 2018

Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952401

28 October 2018

Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952401

28 October 2018

A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952401

28 October 2018

Hepatitis B and C viruses serology in patients with SLE.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952401

28 October 2018

Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: An international inception cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2952401

28 October 2018

How "soft" are soft neurological signs? The relationship of subjective neuropsychiatric complaints to cognitive function in systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/19892750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relation between the level of IgG subclasses and infections in patients with systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/19892750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antigen-specific antibody responses in lupus patients following immunization

1 reference

https://pubmed.ncbi.nlm.nih.gov/19892750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/19892750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome measures to be used in clinical trials in systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/19892750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cutaneous lupus erythematosus disease activity and severity index: Expansion for rheumatology and dermatology

1 reference

https://pubmed.ncbi.nlm.nih.gov/19892750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Studies of serum C-reactive protein in systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/19892750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer screening in patients with systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/19892750

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/ARD.2009.117200

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34187282&oldid=1520891309"